Please assess the completion status of the following clinical trial:

Trial Title: Investigations of Botanicals on Food Intake, Satiety, Weight Loss, and Oxidative Stress

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1/PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~1. healthy individual with normal blood chemistries and platelet counts who has not been diagnosed with diabetes, cardiovascular illness, or other chronic diseases~2. 50 to 70 years of age~3. body mass index between 25 and 39.9 kg/m2~4. for females, post-menopausal (i.e., no menstrual cycle for \> one year).~Exclusion Criteria:~1. Potential participants will be excluded if their scores on the dietary restraint, disinhibition, and perceived hunger scales of the Eating Inventory are high (\>14)~2. Participants who report smoking cigarettes will be excluded because of the effects of nicotine upon taste and appetite~3. Participants who have a diagnosable eating disorder will also be excluded since intentional restriction of eating and binge eating/overeating could increase the variability of the data~4. Participants will be excluded if they are taking anti-depressant medications, anti-psychotic medications, or any medications, botanicals, or other products that may potentially influence appetite, hunger, and/or satiety~5. Participants will be excluded if they report alcohol or substance abuse within 6 months or consumption of \>14 alcohol drinks/week~6. Participants will also be excluded if they report any allergies to the foods used in the study~7. Volunteers will also be ineligible if they have significant medical conditions (e.g., history or clinical manifestation of cardiovascular disease, diabetes, cholelithiasis, liver or renal disease, or cancer)~   * abnormal laboratory markers (e.g., renal or liver abnormalities, elevated potassium levels or hemoglobin and hematocrit below the lower limit of normal)~  * psychiatric or behavioral problems (e.g., eating disorders or a history of drug and alcohol abuse)~  * concomitant medications (e.g., steroids)~8. Volunteers will be screened out if they are unwilling or unable to adhere to different supplement regimens over an eight month period.

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: 70 Years
- Healthy Volunteers: t

Study Arms:
- microcrystalline cellulose (Type: PLACEBO_COMPARATOR): None
- Hydroxycitric acid (Type: ACTIVE_COMPARATOR): 2800 mg divided in three doses per day
- Hydroxycitric Acid (Type: ACTIVE_COMPARATOR): 5400 mg divided into three doses per day

Based on this trial design, predict the completion outcome and termination type (if applicable).